Anticonvulsant Activity of B2, an Adenosine Analog, on Chemical Convulsant-Induced Seizures

作者：Li, Min; Kang, Ruixia; Shi, Jiangong; Liu, Gengtao; Zhang, Jianjun^*

来源：PLos One, 2013, 8(6): e67060.

DOI：10.1371/journal.pone.0067060

• PENTYLENETETRAZOLE-INDUCED SEIZURES
• RECEPTOR ACTIVATION
• FOS EXPRESSION
• GRANULE CELLS
• MOUSE MODEL
• EPILEPSY
• BRAIN
• SUPPRESSION
• BINDING
• STIMULATION

Epilepsy is a chronic neurological disorder characterized by recurrent seizures. However, approximately one-third of epilepsy patients still suffer from uncontrolled seizures. Effective treatments for epilepsy are yet to be developed. N-6-(3-methoxyl-4-hydroxybenzyl) adenine riboside (B2) is a N-6-substitued adenosine analog. Here we describe an investigation of the effects and mechanisms of B2 on chemical convulsant-induced seizures. Seizures were induced in mice by administration of 4-aminopyridine (4-AP), pentylenetetrazol (PTZ), picrotoxin, kainite acid (KA), or strychnine. B2 has a dose-related anticonvulsant effect in these chemical-induced seizure models. The protective effects of B2 include increased latency of seizure onset, decreased seizure occurrence, shorter seizure duration and reduced mortality rate. Radioligand binding and cAMP accumulation assays indicated that B2 might be a functional ligand for both adenosine A(1) and A(2A) receptors. Furthermore, DPCPX, a selective A(1) receptor antagonist, but not SCH58261, a selective A(2A) receptor antagonist, blocked the anticonvulsant effect of B2 on PTZ-induced seizure. c-Fos is a cellular marker for neuronal activity. Immunohistochemical and western blot analyses indicated that B2 significantly reversed PTZ-induced c-Fos expression in the hippocampus. Together, these results indicate that B2 has significant anticonvulsant effects. The anticonvulsant effects of B2 may be attributed to adenosine A(1) receptor activation and reduced neuronal excitability in the hippocampus. These observations also support that the use of adenosine receptor agonist may be a promising approach for the treatment of epilepsy.

• 单位
  天然药物活性物质与功能国家重点实验室; 北京医院; 中国医学科学院北京协和医院; 北京协和医学院